IndiaInfoline » Markets » AUROPHARMA

Aurobindo Pharma Ltd - Share Price

AUROPHARMA

Open

672.00

Prev. Close

673.35

Turnover (lac.)

17,687

Day's High

703.25

Day's Low

672.00

52 Week's High

1,063.90

52 Week's Low

620.50

Book Value

279

Face Value

1

Mkt Cap (Cr.)

41,130

P/E

20.34

EPS

34.5

Divi. Yield

0.57

Aurobindo Pharma LtdFinancials

Switch to
Consolidated
Standalone

Loading ...

Aurobindo Pharma LtdNews & Updates

Peer Comparison

Name LTP PE Mar Cap NP Qtr Div. Yld Sales Qtr BV
Sun Pharmaceuticals Industries Ltd757.55101.82181,761.62809.070.994,120.93113.47
Divis Laboratories Ltd4,604.9558.02122,272.17606.390.431,967.86372.89
Dr Reddys Laboratories Ltd4,570.7047.0276,064.83449.000.553,809.501,049.73
Cipla Ltd897.9526.9672,441.39782.370.563,858.82261.90
Piramal Enterprises Ltd2,627.15245.0862,762.5934.341.19515.35962.90

Figures of Market Capital(Mar Cap), Quaterly Net Profit(NP Qtr) and Quaterly Sales(Sales Qtr) are in Cr.

Aurobindo Pharma LtdSummary & Reports

Aurobindo Pharma Limited (APL), one of the worlds top 5 manufacturers of semi synthetic penicillins was incorporated in 26th December 1986 as a private limited company. Mr. P.V.Ramaprasad Reddy, Mr. K.Nityananda Reddy and a small, highly committed group of professionals founded it. APL is developing, manufacturing and marketing active pharmaceutical ingredients (APIs also referred as bulk actives), intermediates and generic formulation... More

Registered Office

Plot No 2 Maitrivihar,Behind Maithri Vanam Ameerpet,Hyderabad, Telangana,500038

Tell. : +91-40-23736370
Website : http://www.aurobindo.com
Email : info@aurobindo.com/investorgrievances@aurobindo.co

Registrar Office

Karvy Selenium Tow-B, Nanakramguda, Hyderabad-500032 INDIA

Tell. : +91-40-67162222
Website : www.kfintech.com
Email : einward.ris@kfintech.com

Latest Release by aurobindo-pharma-ltd-share-price

View

- <

Reco. Price

Nov 25,2021 01:05 PM

Target Price

Target Returns:

0.00%

Result Express

Aurobindo Pharma Ltd's Q3FY19 consolidated net profit rises 19.7% yoy to Rs712.22cr : Beats Estimates

Dec 09, 2021 01:24 AM

The company’s consolidated revenue stood at Rs5,269.67cr, up 21.53% yoy and 10.91% qoq.

Shareholding Snapshot

Loading ...

Corporate Action

  • Purpose

    Dividend

    Annc. Date

    08 Nov 2021

    Effective. Date

    17 Nov 2021

    Divi. Type

    Interim 2

    Divi.(%)

    150

    Divi. Amt.

    1.5

    The Board of Directors of the Company at its meeting held today, November 8, 2021, has, inter alia, ... More

  • Purpose

    Board Meeting

    Exp. Date

    08 Nov 2021

    Annc. Date

    01 Nov 2021

    Quarterly Results & Second Interim DividendAurobindo Pharma Ltd has informed BSE that a Meeting of t... More

  • Purpose

    Dividend

    Annc. Date

    12 Aug 2021

    Effective. Date

    27 Aug 2021

    Divi. Type

    Interim

    Divi.(%)

    150

    Divi. Amt.

    1.5

    Aurobindo Pharma Ltd has informed BSE that the Board of Directors of the Company at its meeting held... More